Clinical trial
Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With…
NCT00003294 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00003294 |
|---|---|
| Title | Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer |
| Official title | Initial Clinical Evaluation of the Combination of Paclitaxel and Carboplatin With Modulation of Toxicity With GCSF and Amifostine |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, amifostine trihydrate, carboplatin, paclitaxel |
| Enrollment | 24 |
| Start date | May 1, 1997 |
| Primary completion | Apr 1, 1999 |
| Completion | May 1, 2004 |
| First posted | Aug 13, 2004 |
| Last update posted | Mar 7, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: